Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymphoproliferative disorders

  • Daniela Capello
  • , Michaela Cerri
  • , Giuliana Muti
  • , Marco Lucioni
  • , Pierluigi Oreste
  • , Annunziata Gloghini
  • , Eva Berra
  • , Clara Deambrogi
  • , Silvia Franceschetti
  • , Davide Rossi
  • , Oscar Alabiso
  • , Enrica Morra
  • , Alessandro Rambaldi
  • , Antonino Carbone
  • , Marco Paulli
  • , Gianluca Gaidano

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Post-transplant lymphoproliferative disorders (PTLD) derive from antigen-experienced B-cells and represent a major complication of solid organ transplantation. We characterized usage, mutation frequency and mutation pattern of immunoglobulin variable (IGV) gene rearrangements in 50 PTLD (polymorphic PTLD, n = 10; diffuse large B-cell lymphoma, n = 35; and Burkitt/Burkitt-like lymphoma, n = 5). Among PTLD yielding clonal IGV amplimers, a functional IGV heavy chain (IGHV) rearrangement was found in 40/50 (80.0%) cases, whereas a potentially functional IGV light chain rearrangement was identified in 36/46 (78.3%) PTLD. By combining IGHV and IGV light chain rearrangements, 10/50 (20.0%) PTLD carried crippling mutations, precluding expression of a functional B-cell receptor (BCR). Immunohistochemistry showed detectable expression of IG light chains in only 18/43 (41.9%) PTLD. Failure to detect a functional IGV rearrangement associated with lack of IGV expression. Our data suggest that a large fraction of PTLD arise from germinal centre (GC)-experienced B-cells that display impaired BCR. Since a functional BCR is required for normal B-cell survival during GC transit, PTLD development may implicate rescue from apoptosis and expansion of B-cells that have failed the GC reaction. The high frequency of IGV loci inactivation appears to be a peculiar feature of PTLD among immunodeficiency-associated lymphoproliferations.

Lingua originaleInglese
pagine (da-a)212-219
Numero di pagine8
RivistaHematological Oncology
Volume24
Numero di pubblicazione4
DOI
Stato di pubblicazionePubblicato - dic 2006

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

  1. SDG 3 - Salute e benessere
    SDG 3 Salute e benessere

Fingerprint

Entra nei temi di ricerca di 'Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymphoproliferative disorders'. Insieme formano una fingerprint unica.

Cita questo